Journals / Marmara Pharmaceutical Journal / 2017 / Cilt: 21 - Sayı: 2

Synthesis, characterization and biological evaluation of thioureas, acylthioureas and 4-thiazolidinones as anticancer and antiviral agents

Pages
371–384
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

When the anticancer activity of test compounds was examined against PC-3, A549, HeLa, HT-29, MCF-7, SJSA1 and K562 cell lines, the percent proliferation values of these compounds were observed over 61% for all cell lines.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In this study, thiourea derivatives [1-4] were synthesized by using 2-amino-4-substituted pyridine compounds and these compounds have been used as the starting materials for synthesis of 2-imino-1,3-thiazolidin-4-one ring [5, 6].
📊
Key Findings & Data:Two different procedures for 4-thiazolidinone ring closure and synthesis method were optimized.
💡
Conclusion & Impact:When the anticancer activity of test compounds was examined against PC-3, A549, HeLa, HT-29, MCF-7, SJSA1 and K562 cell lines, the percent proliferation values of these compounds were observed over 61% for all cell lines.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

In this study, thiourea derivatives [1-4] were synthesized by using 2-amino-4-substituted pyridine compounds and these compounds have been used as the starting materials for synthesis of 2-imino-1,3-thiazolidin-4-one ring [5, 6]. Two different procedures for 4-thiazolidinone ring closure and synthesis method were optimized. The synthesized compounds were identified by the help of elemental analysis, IR, 1H-NMR, 13C-NMR and mass spectral data while the purities of them were proved with TLC. Synthesized compounds were evaluated for their antiviral and anticancer activity. Antiviral activity against Murine norovirus, Yellow fever, Enterovirus and Chikungunya strains of the test compounds were investigated and EC50 values of these compounds were determined higher than 0,3 µM. Cytotoxicity of test compounds was examined on NIH3T3 cell line. When the anticancer activity of test compounds was examined against PC-3, A549, HeLa, HT-29, MCF-7, SJSA1 and K562 cell lines, the percent proliferation values of these compounds were observed over 61% for all cell lines.

🔖

Cite This Article

KULABAŞ, N., ÖZAKPINAR, Ö. B., ÖZSAVCI, D., LEYSSEN, P., NEYTS, J., KÜÇÜKGÜZEL, İ. (2017). Synthesis, characterization and biological evaluation of thioureas, acylthioureas and 4-thiazolidinones as anticancer and antiviral agents. Marmara Pharmaceutical Journal, Cilt: 21 - Sayı: 2, 371–384. https://ajindex.com/articles/283724

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Kamel MM, Megally Abdo NY. Synthesis of novel1,2,4-triazoles, triazolothiadiazines and triazolothiadiazolesas potential anticancer agents. Eur J Med Chem 2014; 86: 75-80.
  2. Kulabaş N, Tatar E, Bingol Ozakpınar O, Ozsavcı D,Pannecouque C, De Clercq E, Kucukguzel İ. Synthesis andantiproliferative evaluation of novel 2-(4H-1,2,4-triazole-3-ylthio)acetamide derivatives as inducers of apoptosis in cancercells. Eur J Med Chem 2016; 121: 58-70.
  3. Karakuş S, Guniz Kucukguzel Ş, Kucukguzel İ, De Clercq E,Pannecouque C, Andrei G, Pannecouque C, Andrei G, SnoeckR, Sahin F, Bayrak OF. Synthesis, antiviral and anticanceractivity of some novel thioureas derived from N-(4-nitro-2-phenoxyphenyl)-methanesulfonamide. Eur J Med Chem2009; 44: 3591-5.
  4. Kucukguzel İ, Tatar E, Kucukguzel ŞG, Rollas S, De Clercq E.Synthesis of some novel thiourea derivatives obtained from5-[(4-aminophenoxy)methyl]-4-alkyl/aryl-2,4-dihydro-3H-1,2,4-triazole-3-thiones and evaluation as antiviral/anti-HIVand anti-tuberculosis agents. Eur J Med Chem 2008; 43: 381-92.
  5. Liav A, Angala SK, Brennan PJ, Jackson M. N-DAldopentofuranosyl-N’-[p-(isoamyloxy)phenyl]-thioureaderivatives: Potential anti-TB therapeutic agents. Bioorg MedChem Lett 2008; 18: 2649-51.
  6. Vega-Perez JM, Perinan I, Argandona M, Vega-Holm M, Palo-Nieto C, Burgos-Moron E, Lopez-Lazaro M, Vargas C, NietoJJ, Iglesias-Guerra F. Isoprenyl-thiourea and urea derivativesas new farnesyl diphosphate analogues: Synthesis and in vitroantimicrobial and cytotoxic activities. Eur J Med Chem 2012;58: 591-612.
  7. Tatar E, Karakuş S, Kucukguzel ŞG, Oktem Okullu S,Unubol N, Kocagoz T, De Clercq E, Andrei G, Snoeck R,Pannecouque C, Kalaycı S, Şahin F, Sriram D, Yogeeswari P,Kucukguzel İ. Design, Synthesis, and Molecular DockingStudies of a Conjugated Thiadiazole–Thiourea Scaffold asAntituberculosis Agents. Biol Pharm Bull 2016; 39: 502-15.
  8. Kucukguzel İ, Kucukguzel ŞG, Rollas S, Kiraz M. Some3-thioxo/alkylthio-1,2,4-triazoles with a substituted thioureamoiety as possible antimycobacterials. Bioorg Med Chem Lett2001; 11: 1703-7.
  9. Zhao F, Xiao JH, Wang Y, Li S. Synthesis of thiourea derivativesas CCR4 antagonists. Chin Chem Lett 2009; 20: 296-9.
  10. Ghorab MM, Alsaid MS, Al-Dosary MS, Nissan YM, AttiaSM. Design, synthesis and anticancer activity of some novelthioureido‑benzenesulfonamides incorporated biologicallyactive moieties. Chem Cent J 2016; 10: 1-13.
  11. Manjula SN, Malleshappa Noolvi N, Vipan Parihar K,Manohara Reddy SA, Ramani V, Gadad AK, Singh G, GopalanKutty N, Malli